<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ersoy SC</submitter><funding>NHLBI NIH HHS</funding><pagination>173-181</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5478264</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20</volume><pubmed_abstract>The emergence and prevalence of antibiotic-resistant bacteria are an increasing cause of death worldwide, resulting in a global 'call to action' to avoid receding into an era lacking effective antibiotics. Despite the urgency, the healthcare industry still relies on a single in vitro bioassay to determine antibiotic efficacy. This assay fails to incorporate environmental factors normally present during host-pathogen interactions in vivo that significantly impact antibiotic efficacy. Here we report that standard antimicrobial susceptibility testing (AST) failed to detect antibiotics that are in fact effective in vivo; and frequently identified antibiotics that were instead ineffective as further confirmed in mouse models of infection and sepsis. Notably, AST performed in media mimicking hos</pubmed_abstract><journal>EBioMedicine</journal><pubmed_title>Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing.</pubmed_title><pmcid>PMC5478264</pmcid><funding_grant_id>P01 HL131474</funding_grant_id><funding_grant_id>R01 HL125352</funding_grant_id><pubmed_authors>Smith JW</pubmed_authors><pubmed_authors>House JK</pubmed_authors><pubmed_authors>Mahan MJ</pubmed_authors><pubmed_authors>Barnes L</pubmed_authors><pubmed_authors>Ersoy SC</pubmed_authors><pubmed_authors>Heithoff DM</pubmed_authors><pubmed_authors>Marth JD</pubmed_authors><pubmed_authors>Tripp GK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing.</name><description>The emergence and prevalence of antibiotic-resistant bacteria are an increasing cause of death worldwide, resulting in a global 'call to action' to avoid receding into an era lacking effective antibiotics. Despite the urgency, the healthcare industry still relies on a single in vitro bioassay to determine antibiotic efficacy. This assay fails to incorporate environmental factors normally present during host-pathogen interactions in vivo that significantly impact antibiotic efficacy. Here we report that standard antimicrobial susceptibility testing (AST) failed to detect antibiotics that are in fact effective in vivo; and frequently identified antibiotics that were instead ineffective as further confirmed in mouse models of infection and sepsis. Notably, AST performed in media mimicking hos</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jun</publication><modification>2025-04-19T19:05:06.584Z</modification><creation>2019-03-27T02:48:05Z</creation></dates><accession>S-EPMC5478264</accession><cross_references><pubmed>28579300</pubmed><doi>10.1016/j.ebiom.2017.05.026</doi></cross_references></HashMap>